openPR Logo
Press release

Gastritis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

03-20-2017 04:35 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Gastritis Treatment Market – Global Industry Insights,

Gastritis is the irritation, or inflammation, or erosion of the stomach lining. Gastritis may be acute or chronic. The disease may show some symptoms or the symptoms may be dormant. Usually, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis may lead to stomach tumors, bleeding, and stomach ulcers. Gastritis is usually caused by the bacteria helicobacter pylori or by the use of nonsteroidal anti-inflammatory drugs or NSAIDs. Other possible causes include smoking, cocaine, alcohol, and autoimmune diseases, among others. Treatment of gastritis includes H2 blockers, antacids, or proton pump inhibitors. In an acute gastritis attack, consumption of viscous lidocaine may be of assistance. If H. pylori are present, it may be cured with a combination drug therapy of antibiotics such as clarithromycin and amoxicillin. Gastritis can be cured by proper treatment; hence the demand of gastritis treatment is poised to rise in the foreseeable future.

Chronic gastritis is one of the major diseases that affect a significant population of the globe and its prevalence is rising, according to a research report published in National Center for Biotechnology Information. It is estimated that nearly half the population of the world suffers from infection by helicobacter pylori, one of the main agent causing gastritis. There has been a growing concern about the prevalence of the disease around the world. As the disease is a curable disease, demand for its treatment is projected to increase at a steady pace. Technological advancements have brought about a sea change in the treatment of gastritis. According to a report by National Center for Biotechnology Information, patients with atropic gastritis (mucous glad metalapsia waste away) have higher chances of cancer, when compared to other forms of gastritis.

Access Full Report with TOC: https://www.coherentmarketinsights.com/ongoing-insight/toc/148

Gastritis Treatment Market Taxonomy

On the basis of drug class, the global gastritis treatment market is classified into:

Acid blocking medicines
Antibiotics
Antacids
Acid reducing medicines
Others

On the basis of end user, the global gastritis treatment market is classified into:

Government
Hospitals
Medical Practitioners
Others

Gastritis has been broadly categorized into three segments – acute gastritis (caused by NSAIDs and high alcohol consumption), chronic gastritis (variety of complication in the gastric tissues), and erosion of metalapsia or atrophic gastritis. Chronic gastritis is the most prevalent form of gastritis. Hence, the treatment of chronic gastritis will be the most promising market opportunity in the coming years.

You can also get exclusive discount on this CMI report by clicking on this link: https://www.coherentmarketinsights.com/insight/request-discount/148

Increasing prevalence of chronic gastritis, especially in the geriatric population offers promising growth for gastritis treatment market

There has been an increasing prevalence of gastritis, especially in the geriatric people around the globe. According to a report by National Center for Biotechnology Information, there were about 90 million new cases of gastritis in 2013. Gastritis and deodenitis (inflammation of the duodenum) caused about 60,000 deaths in 2013. As life expectancy has been increasing, the geriatric population of the globe is also on the rise. According to the same report, the prevalence of gastritis increase with age. Therefore, the demand for gastritis treatment will increase at a steady rate over the forecast period.

North America accounts for the maximum share of the market in the present scenario. Increasing prevalence of gastritis due to high alcohol consumption and unhealthy lifestyle and food habits are some of the reasons for the region’s dominance. However, Asia Pacific is expected to offer a lucrative market for the growth of the gastritis treatment market. The incidences of H pylori infection are high in Asia Pacific and other developing countries. Additionally, the prevalence of gastric adenocarcinomas and multifocal atrophic gastritis is high in these regions. Increase in geriatric population, better awareness about healthcare, and increased health care spending are some of the reasons that will fuel the growth of the gastritis treatment market in this region. Moreover, high occurrence of viral diseases, and autoimmune diseases, and lack of awareness about contagious diseases will propel the growth of the market.

Request a sample copy of this report:https://www.coherentmarketinsights.com/insight/request-sample/148

The gastritis treatment market is highly fragmented in nature. Many companies are investing heavily in their research and development activities to come up with different treatments of the disease. Companies operating in the gastritis treatment market in the current scenario are Otsuka Indonesia PT, AstraZeneca PLC, Zydus Cadila Healthcare Limited, Novartis AG, and others.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: http://healthcaremarketconsulting.blogspot.in/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastritis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024 here

News-ID: 474441 • Views:

More Releases from Pharmaceutical Report By CMI

Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Angina Pectoris Treatment Market - Global Industry Insights 2025
Angina Pectoris Treatment Market - Global Industry Insights 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Glucagon-Like Peptide-1 (Glp-1) Analogs Market - Global Industry Insights - 2025
Glucagon-Like Peptide-1 (Glp-1) Analogs Market - Global Industry Insights - 2025
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024
U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024
Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromorphone, methylphenidate, oxycodone, and oxymorphone, which are generally prescribed for pain management. Opioids are also prescribed for treatment of cough and diarrhea. According to the survey conducted by Center for Behavioral Health Statistics and Quality (CBHSQ), in 2015, out of 20.5 million about 2 million

All 5 Releases


More Releases for Gastritis

Acute Gastritis Treatment Market 2022 Size & Industry Forecast by 2027
The Acute Gastritis Treatment Market research report discusses the key drivers influencing global growth, opportunities, current challenges and the risks faced by key players and the market as a whole Acute Gastritis Treatment Market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. Acute Gastritis Treatment Market is
Gastritis Treatment Market Professional Inspection Report 2020-2027
Global Gastritis Treatment Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Gastritis Treatment Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and
Gastritis Treatment Market: Moving Towards a Brighter Future
Global Gastritis Treatment Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Gastritis Treatment Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and
Gastritis Overview - Symptoms, Types, causes and Gastritis Treatment
An Overview: Gastritis is a general term that refers to a group of conditions, each identifiable by inflammation, erosion, or irritation in the lining of the stomach. It can appear in a number of different forms, some more serious than others, and require different methods of treatment. Whether you have gastritis or not, knowing precisely what it is, what symptoms it can cause, and how to go about treating it is important
Atrophic Gastritis Global Clinical Trials Review, H1, 2017
"The Report Atrophic Gastritis Global Clinical Trials Review, H1, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Atrophic Gastritis Clinical Trials Market Summary GlobalData's clinical trial report, Atrophic Gastritis Global Clinical Trials Review, H1, 2017" provides an overview of Atrophic Gastritis clinical trials scenario. This report provides top line data relating to the clinical trials on Atrophic Gastritis. Report includes an
Gastritis Treatment Market – Global Industry Insights 2024
Gastritis is the irritation, or inflammation, or erosion of the stomach lining. Gastritis may be acute or chronic. The disease may show some symptoms or the symptoms may be dormant. Usually, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis may lead to stomach tumors, bleeding, and stomach ulcers. Gastritis is usually caused by the bacteria helicobacter pylori or by the use of nonsteroidal anti-inflammatory drugs or NSAIDs. Other